Abstract
Evidence for immune mechanisms in neuroblastoma patients against the tumor include: (1) The finding of infiltrates of lymphocytes in the tumors from patients having a good prognosis; (2) in tissue culture there appears to be a lethal immune reaction by the lymphocytes of neuroblastoma patients against the tumor cells; (3) a less constant lethal immune activity by the plasma against tumor cells in tissue culture; and (4) unfavorable immune factor has been demonstrated which is a humoral “blocking antibody.” Among infants in the first year of life there is a correlation between higher blood lymphocyte counts at diagnosis and survival, and between lower counts and nonsurvival.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
